Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherene Loi

Showing results (51-60 of 325) with videos related to

Pageof 33
Sort By:
Pathology|January 5, 2017
Tumour-infiltrating lymphocytes and the emerging role of immunotherapy in breast cancerStephen J Luen, Peter Savas, Stephen B Fox, et al.
Current Opinion in Oncology|September 16, 2011
HER2-overexpressing breast cancer: time for the cure with less chemotherapy?Sherene Loi, Evandro de Azambuja, Lina Pugliano, et al.
Breast (Edinburgh, Scotland)|July 27, 2025
Biomarkers of response and resistance to immune checkpoint inhibitors in breast cancerMichelle Li, François Panet, Vittoria Barberi, et al.
Biomedicines|April 23, 2022
Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future DirectionsSteven David, Jennifer Tan, Shankar Siva, et al.
Cancer Journal (Sudbury, Mass.)|January 21, 2021
Tumor-Infiltrating Lymphocyctes in Triple-Negative Breast Cancer: Update for 2020Lauren C Brown, Roberto Salgado, Stephen J Luen, et al.
Frontiers in Oncology|August 22, 2017
Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future DirectionsLironne Wein, Peter Savas, Stephen J Luen, et al.
Breast (Edinburgh, Scotland)|February 24, 2015
Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancyHatem A Azim, Andrea Vingiani, Fedro Peccatori, et al.
Nature Reviews. Clinical Oncology|July 22, 2015
Precision medicine for metastatic breast cancer--limitations and solutionsMonica Arnedos, Cecile Vicier, Sherene Loi, et al.
Plos One|September 1, 2018
Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arraysVinu Jose, Debora Fumagalli, Françoise Rothé, et al.
Cancer Research|June 8, 2011
Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumorsStephen R Mattarollo, Sherene Loi, Helene Duret, et al.
Pageof 33

Showing results (51-60 of 325) with videos related to

Sort By:
Pageof 33
Pathology|January 5, 2017
Tumour-infiltrating lymphocytes and the emerging role of immunotherapy in breast cancerStephen J Luen, Peter Savas, Stephen B Fox, et al.
Current Opinion in Oncology|September 16, 2011
HER2-overexpressing breast cancer: time for the cure with less chemotherapy?Sherene Loi, Evandro de Azambuja, Lina Pugliano, et al.
Breast (Edinburgh, Scotland)|July 27, 2025
Biomarkers of response and resistance to immune checkpoint inhibitors in breast cancerMichelle Li, François Panet, Vittoria Barberi, et al.
Biomedicines|April 23, 2022
Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future DirectionsSteven David, Jennifer Tan, Shankar Siva, et al.
Cancer Journal (Sudbury, Mass.)|January 21, 2021
Tumor-Infiltrating Lymphocyctes in Triple-Negative Breast Cancer: Update for 2020Lauren C Brown, Roberto Salgado, Stephen J Luen, et al.
Frontiers in Oncology|August 22, 2017
Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future DirectionsLironne Wein, Peter Savas, Stephen J Luen, et al.
Breast (Edinburgh, Scotland)|February 24, 2015
Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancyHatem A Azim, Andrea Vingiani, Fedro Peccatori, et al.
Nature Reviews. Clinical Oncology|July 22, 2015
Precision medicine for metastatic breast cancer--limitations and solutionsMonica Arnedos, Cecile Vicier, Sherene Loi, et al.
Plos One|September 1, 2018
Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arraysVinu Jose, Debora Fumagalli, Françoise Rothé, et al.
Cancer Research|June 8, 2011
Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumorsStephen R Mattarollo, Sherene Loi, Helene Duret, et al.
Pageof 33